Patents by Inventor Arnauld Michel DIDIERLAURENT

Arnauld Michel DIDIERLAURENT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11679153
    Abstract: The present invention relates to methods for inducing an immune response, in particular methods for adjuvanting the immune response to an antigen comprising the separate administration of a saponin and a TLR4 agonist.
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: June 20, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Margherita Coccia, Arnauld Michel Didierlaurent
  • Patent number: 11045542
    Abstract: The invention provides a pro-resolving mediator for use in the reduction of reactogenicity induced by administration of a vaccine or immunogenic composition comprising at least an antigen, and vaccines or immunogenic compositions comprising such a pro-resolving mediator.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: June 29, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Arnauld Michel Didierlaurent, Caroline Christiane Herve
  • Publication number: 20210100899
    Abstract: The present invention relates to methods for inducing an immune response, in particular methods for adjuvanting the immune response to an antigen comprising the separate administration of a saponin and a TLR4 agonist.
    Type: Application
    Filed: November 27, 2020
    Publication date: April 8, 2021
    Applicant: GlaxoSmithKline Biologicals SA
    Inventors: Margherita COCCIA, Arnauld Michel DIDIERLAURENT
  • Patent number: 10881731
    Abstract: The present invention relates to methods for inducing an immune response, in particular methods for adjuvanting the immune response to an antigen comprising the separate administration of a saponin and a TLR4 agonist.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: January 5, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Margherita Coccia, Arnauld Michel Didierlaurent
  • Publication number: 20200000912
    Abstract: The present invention relates to methods for inducing an immune response, in particular methods for adjuvanting the immune response to an antigen comprising the separate administration of a saponin and a TLR4 agonist.
    Type: Application
    Filed: December 19, 2017
    Publication date: January 2, 2020
    Inventors: Margherita COCCIA, Arnauld Michel DIDIERLAURENT